FARALLON CAPITAL MANAGEMENT LLC

Q2 2025 13F-HR Detailed Holdings

Location
San Francisco, CA
Holdings as of
6/30/2025
Date filed
8/14/2025
Form type
13F-HR
Num holdings
141
Total value ($000)
$23,178,106
Net value change ($000)
+5,242,309 (29.2%)
New positions
21
Sold out positions
15
Turnover %
30.7%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
SPY 3,398,175 NEW
AHC 804,225 NEW
AMZN 665,761 NEW
AKX 350,211 NEW
AON 330,337 87.3%
HIMS 174,415 74.2%
NTRA 171,490 26.7%
AZEK 170,735 NEW
IBIT 158,489 58.4%
BBIO 143,001 72.2%
Top Reduces (Value $000, Stocks/ETFs)
Intra-Cellular Therapies, Inc. -403,016 -100.0%
UNH -279,976 -35.7%
SRPT -149,430 -100.0%
MCK -141,294 -38.0%
NYT -129,011 -29.1%
EXEL -125,172 -15.0%
BHVN -115,709 -100.0%
INTU -93,222 -18.1%
SGI -79,415 -100.0%
YMM -75,639 -80.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,869,702 (8.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None